Not applicableNot Yet RecruitingNCT06879470What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LymphomaWho this might be right forB-Non Hodgkin Lymphoma He Huang 24
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Early research (Phase 1)Looking for participantsNCT05801913What this trial is testingGenetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin LymphomaWho this might be right forHigh Grade B-Cell Non-Hodgkin's LymphomaIntermediate Grade B-Cell Non-Hodgkin's LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+1 more City of Hope Medical Center 15
Early research (Phase 1)Study completedNCT01593696What this trial is testingAnti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or LymphomaWho this might be right forALLB Cell LymphomaLeukemia+2 more National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Early research (Phase 1)Not Yet RecruitingNCT07032324What this trial is testingA Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )Who this might be right forB-Cell Non-Hodgkin Lymphoma Qian Wenbin 27
Early research (Phase 1)Looking for participantsNCT06026319What this trial is testingCD79b-19 CAR T Cells in Non-Hodgkin LymphomaWho this might be right forNon-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more Marcela V. Maus, M.D.,Ph.D. 24
Early research (Phase 1)Looking for participantsNCT07053670What this trial is testingA Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )Who this might be right forB-Cell Non-Hodgkin Lymphoma Tongji Hospital 27
Post-approval studies (Phase 4)UnknownNCT04152577What this trial is testingR2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHLWho this might be right forLymphoma, B-Cell Shandong Provincial Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965What this trial is testingFrontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCLWho this might be right forMantle Cell Lymphoma (MCL) Miltenyi Biomedicine GmbH 52
Early research (Phase 1)Active Not RecruitingNCT05206357What this trial is testingStudy of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of EpcoritamabWho this might be right forNon-hodgkin Lymphoma Genmab 17
Early research (Phase 1)Active Not RecruitingNCT04970901What this trial is testingEvaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)Who this might be right forB-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma ADC Therapeutics S.A. 154
Testing effectiveness (Phase 2)UnknownNCT05143112What this trial is testingAllogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell LymphomaWho this might be right forNon-hodgkin Lymphoma,B Cell Shenzhen University General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT00974792What this trial is testingCombination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Cancer Research UK 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06230224What this trial is testingA Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forB-Cell Non-Hodgkin Lymphoma (B-NHL) Regeneron Pharmaceuticals 216
Early research (Phase 1)Ended earlyNCT05987605What this trial is testingPhase I/II Clinical Study of 1A46 Drug SubstanceWho this might be right forAdvanced Malignancies BioRay Pharmaceutical Co., Ltd. 4
Not applicableStudy completedNCT00712556What this trial is testingPET Study in Patients With Non-Hodgkin LymphomaWho this might be right forLymphoma Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT07432022What this trial is testingA Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forCombination TherapyAggressive B-Cell Non-Hodgkin LymphomaEMB07+1 more Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Testing effectiveness (Phase 2)Ended earlyNCT02151903What this trial is testingOpen-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHLWho this might be right forB-cell Non-Hodgkin Lymphoma Alopexx Oncology, LLC 5
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12